Novedades en relación con la transparencia del precio de los medicamentos

The purpose of this article is to provide some analysis on the latest developments in the area of price transparency of medicines for human use. This article analyses a report issued by the Ministry of Health that defends maintaining a certain degree of confidentiality in the price of medicines, as well as the European Commission’s position on the price of vaccines against COVID-19. Finally, it analyses the ruling of the Constitutional Court declaring unconstitutional some precepts of the Public Sector Contracts Law.